Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of <i>Acinetobacter baumannii</i>.

"data availability all genome sequencing data described in this manuscript have been deposited at ddbj/ena/genbank as part of bioproject prjna988092 under the accession jauemn000000000 - jaueoy000000000 . supplemental tables s1 to s3 aac 00665-23-s0002 xlsx data availability all genome sequencing data described in this manuscript have been deposited at ddbj/ena/genbank as part of bioproject prjna988092"

"Samir H. Moussa, Adam B. Shapiro, Sarah M. Mcleod, Ramkumar Iyer, Nicole M. Carter, and Alita A. Miller are current or former employees of Innoviva Specialty Therapeutics, Inc. an affiliate of Entasis Therapeutics Inc."

"This study was sponsored by Entasis Therapeutics Inc., a wholly owned subsidiary of Innoviva Specialty Therapeutics, Inc. S.H.M., A.B.S., S.M.M., R.I., N.M.C., and A.A.M. are current or former employees of Innoviva Specialty Therapeutics, Inc. All authors generated and analyzed data and have read and approved the final manuscript."